|
Volumn 7, Issue 3, 2006, Pages 254-258
|
What makes a good prion?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID PROTEIN;
ANTIPRION AGENT;
ANTIVIRUS AGENT;
NEW DRUG;
PRION PROTEIN;
UNCLASSIFIED DRUG;
FUNGAL PROTEIN;
ALZHEIMER DISEASE;
AMYGDALOID NUCLEUS;
APOPTOSIS;
ATOMIC FORCE MICROSCOPY;
CONFERENCE PAPER;
DEGENERATIVE DISEASE;
GENE MUTATION;
GENETIC CODE;
HUMAN;
MEDICAL RESEARCH;
NERVE CELL NETWORK;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE;
PATHOGENESIS;
PHENOTYPE;
PRION;
PRION DISEASE;
PRIORITY JOURNAL;
PROTEIN DETERMINATION;
PROTEIN DOMAIN;
PROTEIN EXPRESSION;
PROTEIN FOLDING;
PROTEIN FUNCTION;
PROTEIN PROTEIN INTERACTION;
PROTEIN STRUCTURE;
PROTEIN SYNTHESIS;
SITE DIRECTED MUTAGENESIS;
STRUCTURE ANALYSIS;
VIRUS INHIBITION;
VIRUS REPLICATION;
VIRUS STRAIN;
YEAST;
ANIMAL;
ARTICLE;
CHEMISTRY;
GENETICS;
METABOLISM;
ORGANIZATION;
PATHOLOGY;
UNITED STATES;
MAMMALIA;
ANIMALS;
CONGRESSES;
FUNGAL PROTEINS;
NEW HAMPSHIRE;
PRION DISEASES;
PRIONS;
|
EID: 33645752278
PISSN: 1469221X
EISSN: 14693178
Source Type: Journal
DOI: 10.1038/sj.embor.7400642 Document Type: Conference Paper |
Times cited : (3)
|
References (5)
|